MRNA: the balance sheet

MyFinsight

For the quarter ending 2026-03-31, MRNA has $11,488M in assets. $4,080M in debts. $1,908M in cash and cash equivalents.

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Cash and cash equivalents	1,908	2,595	1,132	1,279
Investments	3,297	3,204	3,372	3,852
Accounts receivable, net	71	184	1,046	36
Inventory	146	153	332	240
Prepaid expenses and other current assets	348	408	716	764
Total current assets	5,770	6,544	6,598	6,171
Investments, non-current	2,251	2,336	2,143	2,374
Property, plant and equipment, net	2,086	2,134	2,126	2,169
Right-of-use assets, operating leases	706	719	738	750
Other non-current assets	675	605	530	546
Total assets	11,488	12,338	12,135	12,010

Accounts payable	161	317	267	175
Accrued liabilities	1,912	1,386	1,178	987
Deferred revenue	102	99	163	218
Other current liabilities	220	185	73	192
Total current liabilities	2,395	1,987	1,681	1,572
Deferred revenue, non-current	154	153	157	65
Operating lease liabilities, non-current	645	653	660	666
Financing lease liabilities, non-current	13	20	26	32
Long-term debt	590	590	-	-
Other non-current liabilities	283	285	281	276
Total liabilities	4,080	3,688	2,805	2,611
Additional paid-in capital	1,503	1,382	1,254	1,127
Accumulated other comprehensive income	25	45	27	23
Retained earnings	5,880	7,223	8,049	8,249
Total stockholders equity	7,408	8,650	9,330	9,399
Total liabilities and stockholders equity	11,488	12,338	12,135	12,010

Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.